Production (Stage)
Amneal Pharmaceuticals, Inc.
AMRX
$7.16
-$0.03-0.42%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 12.20M | -31.08M | -156.00K | 5.99M | -91.64M |
| Total Depreciation and Amortization | 60.16M | 66.13M | 58.96M | 55.57M | 55.53M |
| Total Amortization of Deferred Charges | 6.81M | 26.44M | 1.44M | 933.00K | 6.80M |
| Total Other Non-Cash Items | 34.62M | 34.74M | 38.76M | 33.88M | 36.88M |
| Change in Net Operating Assets | -106.38M | 21.86M | 42.77M | -56.72M | -11.97M |
| Cash from Operations | 7.41M | 118.08M | 141.77M | 39.66M | -4.41M |
| Capital Expenditure | -14.12M | -22.46M | -17.11M | -10.70M | -10.06M |
| Sale of Property, Plant, and Equipment | 524.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | 7.01M | 0.00 | 4.99M | -- |
| Other Investing Activities | -4.20M | -600.00K | -3.60M | -750.00K | -9.70M |
| Cash from Investing | -17.80M | -16.06M | -20.71M | -6.47M | -19.76M |
| Total Debt Issued | 218.00M | 0.00 | 0.00 | 0.00 | 48.00M |
| Total Debt Repaid | -235.53M | -55.54M | -87.21M | -27.00M | -63.38M |
| Issuance of Common Stock | 69.00K | 151.00K | 617.00K | 358.00K | 28.00K |
| Repurchase of Common Stock | -21.64M | -387.00K | -194.00K | -159.00K | -7.21M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -68.00K | -5.43M | -5.56M | -8.29M | -594.00K |
| Cash from Financing | -39.17M | -61.20M | -92.35M | -35.09M | -23.16M |
| Foreign Exchange rate Adjustments | -470.00K | -740.00K | 7.00K | -101.00K | -165.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -50.03M | 40.08M | 28.72M | -2.00M | -47.49M |